The Inflation Reduction Act of 2022 caps out-of-pocket prescription drug costs for Medicare Part D enrollees at $2,000 per year starting in 2025, which is expected to relieve pressure on the Medicare program and encourage Part D plans to negotiate better for their enrollees.